Ozempic Supply Is Running Low: Here's Why That Can Be A Problem
Portfolio Pulse from Aaron Bry
The supply of diabetes drug Ozempic, also used for weight loss, is running low in the US. The shortage is affecting other similar drugs like Mounjaro from Eli Lilly And Co. The shortage has led to people ordering off-brand versions online, which can be dangerous. The shortage has also affected Calibrate, a telehealth company focused on weight-loss services, leading to its CEO stepping down.
October 31, 2023 | 9:23 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Eli Lilly's Mounjaro is also affected by the shortage of diabetes drugs used for weight loss.
The shortage of diabetes drugs used for weight loss is likely to affect the sales of Eli Lilly's Mounjaro, potentially leading to a negative impact on the company's stock.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Novo Nordisk's Ozempic is in limited supply, leading to patients resorting to potentially dangerous off-brand versions.
The shortage of Novo Nordisk's Ozempic could negatively impact the company's reputation and sales, potentially leading to a negative impact on the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100